In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease

OBJECTIVE: Perfluorohexyloctane (PFHO) MIEBO(TM), formerly (NOV03) is a single component, water-free eye drop approved by the Food and Drug Administration in the United States for the treatment of dry eye disease. We evaluated the in vitro inhibitory effect of PFHO on the evaporation rate (R(evap))...

Descripción completa

Detalles Bibliográficos
Autores principales: Vittitow, Jason, Kissling, Robert, DeCory, Heleen, Borchman, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300294/
https://www.ncbi.nlm.nih.gov/pubmed/37389230
http://dx.doi.org/10.1016/j.curtheres.2023.100704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300294/
https://www.ncbi.nlm.nih.gov/pubmed/37389230
http://dx.doi.org/10.1016/j.curtheres.2023.100704

Ejemplares similares